Regulation of p53 expression, phosphorylation and subcellular localization by a G-protein-coupled receptor

Oncogene

Volumn 28, Issue 41, 2009, Pages 3619-3630

  Solyakov, L ^a   Sayan, E ^a   Riley, J ^b   Pointon, A ^b   Tobin, A B ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

^b MRC TOXICOLOGY UNIT   (United Kingdom)

Author keywords

Apoptosis; G protein coupled receptor; M3 muscarinic; Mitochondria; P53; SH SY5Y

Indexed keywords

ETOPOSIDE; G PROTEIN COUPLED RECEPTOR; MUSCARINIC M3 RECEPTOR; PROTEIN P53; SERINE;

ANIMAL CELL; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL MIGRATION; CELL STRAIN SH SY5Y; CELL TYPE; CELLULAR DISTRIBUTION; CHO CELL; CONTROLLED STUDY; DNA DAMAGE; DRUG INHIBITION; FEMALE; GENE TRANSLOCATION; HUMAN; HUMAN CELL; MITOCHONDRION; NEUROBLASTOMA CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION;

ANIMALS; APOPTOSIS; CASPASES; CELL LINE, TUMOR; CHO CELLS; CRICETINAE; CRICETULUS; ENZYME ACTIVATION; ETOPOSIDE; GENE EXPRESSION REGULATION; HUMANS; INTRACELLULAR SPACE; MITOCHONDRIA; PHOSPHORYLATION; PROTEIN TRANSPORT; RECEPTOR, MUSCARINIC M3; TRANSFECTION; TUMOR SUPPRESSOR PROTEIN P53;

CRICETULUS GRISEUS;

EID: 70350061944     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2009.225     Document Type: Article

References (62)

1. Bean LJ, Stark GR. (2001). Phosphorylation of serines 15 and 37 is necessary for efficient accumulation of p53 following irradiation with UV. Oncogene 20: 1076-1084.
2. Bode AM, Dong Z. (2004). Post-translational modification of p53 in tumorigenesis. Nat Rev Cancer 4: 793-805.
3. Bourdon JC. (2007). p53 and its isoforms in cancer. Br J Cancer 97: 277-282.
4. Brooks CL, Gu W. (2003). Ubiquitination, phosphorylation and acetylation: the molecular basis for p53 regulation. Curr Opin Cell Biol 15: 164-171.
5. Brown JM, Attardi LD. (2005). The role of apoptosis in cancer development and treatment response. Nat Rev Cancer 5: 231-237.
6. Budd DC, McDonald J, Emsley N, Cain K, Tobin AB. (2003). The C-terminal tail of the M3-muscarinic receptor possesses anti-apoptotic properties. J Biol Chem 278: 19565-19573.
7. Budd DC, Spragg EJ, Ridd K, Tobin AB. (2004). Signalling of the M3-muscarinic receptor to the anti-apoptotic pathway. Biochem J 381: 43-49.
8. Chao C, Saito S, Anderson CW, Appella E, Xu Y. (2000). Phosphorylation of murine p53 at ser-18 regulates the p53 responses to DNA damage. Proc Natl Acad Sci USA 97: 11936-11941.
9. Chehab NH, Malikzay A, Stavridi ES, Halazonetis TD. (1999). Phosphorylation of Ser-20 mediates stabilization of human p53 in response to DNA damage. Proc Natl Acad Sci USA 96: 13777-13782.
10. Chen CK, Burns ME, Spencer M, Niemi GA, Chen J, Hurley JB et al. (1999). Abnormal photoresponses and light-induced apoptosis in rods lacking rhodopsin kinase. Proc Natl Acad Sci USA 96: 3718-3722.
11. Chipuk JE, Green DR. (2003). p53's believe it or not: lessons on transcription-independent death. J Clin Immunol 23: 355-361.
12. Chitaley K, Wingard CJ, Clinton Webb R, Branam H, Stopper VS, Lewis RW et al. (2001). Antagonism of Rho-kinase stimulates rat penile erection via a nitric oxide-independent pathway. Nat Med 7: 119-122.
13. Courtois S, de Fromentel CC, Hainaut P. (2004). p53 protein variants: structural and functional similarities with p63 and p73 isoforms. Oncogene 23: 631-638.
14. Cui H, Schroering A, Ding HF. (2002). p53 mediates DNA damaging drug-induced apoptosis through a caspase-9-dependent pathway in SH-SY5Y neuroblastoma cells. Mol Cancer Ther 1: 679-686.
15. Dale LB, Bhattacharya M, Anborgh PH, Murdoch B, Bhatia M, Nakanishi S et al. (2000). G protein-coupled receptor kinase-mediated desensitization of metabotropic glutamate receptor 1A protects against cell death. J Biol Chem 275: 38213-38220.
16. De Sarno P, Shestopal SA, King TD, Zmijewska A, Song L, Jope RS. (2003). Muscarinic receptor activation protects cells from apoptotic effects of DNA damage, oxidative stress, and mitochondrial inhibition. J Biol Chem 278: 11086-11093.
17. De Sarno P, Shestopal SA, Zmijewska AA, Jope RS. (2005). Anti-apoptotic effects of muscarinic receptor activation are mediated by Rho kinase. Brain Res 1041: 112-115.
18. DeFea KA, Vaughn ZD, O'Bryan EM, Nishijima D, Dery O, Bunnett NW. (2000). The proliferative and antiapoptotic effects of substance P are facilitated by formation of a beta-arrestin-dependent scaffolding complex. Proc Natl Acad Sci USA 97: 11086-11091.
19. Diao CT, Li L, Lau SY, Wong TM, Wong NS. (2000). kappa-Opioid receptor potentiates apoptosis via a phospholipase C pathway in the CNE2 human epithelial tumor cell line. Biochim Biophys Acta 1499: 49-62.
20. Dorsam RT, Gutkind JS. (2007). G-protein-coupled receptors and cancer. Nat Rev Cancer 7: 79-94.
21. Dumont P, Leu JI, Della Pietra 3rd AC, George DL, Murphy M. (2003). The codon 72 polymorphic variants of p53 have markedly different apoptotic potential. Nat Genet 33: 357-365.
22. Erster S, Mihara M, Kim RH, Petrenko O, Moll UM. (2004). in vivo mitochondrial p53 translocation triggers a rapid first wave of cell death in response to DNA damage that can precede p53 target gene activation. Mol Cell Biol 24: 6728-6741.
23. Fang X, Yu S, LaPushin R, Lu Y, Furui T, Penn LZ et al. (2000). Lysophosphatidic acid prevents apoptosis in fibroblasts via G(i)-protein- mediated activation of mitogen-activated protein kinase. Biochem J 352(Part 1): 135-143.
24. Haupt S, Haupt Y. (2006). Importance of p53 for cancer onset and therapy. Anticancer Drugs 17: 725-732.
25. Hu T, Miller CM, Ridder GM, Aardema MJ. (1999). Characterization of p53 in Chinese hamster cell lines CHO-K1, CHO-WBL, and CHL: implications for genotoxicity testing. Mutat Res 426: 51-62.
26. Kakudo Y, Shibata H, Otsuka K, Kato S, Ishioka C. (2005). Lack of correlation between p53-dependent transcriptional activity and the ability to induce apoptosis among 179 mutant p53's. Cancer Res 65: 2108-2114.
27. Klabunde T, Hessler G. (2002). Drug design strategies for targeting G-protein-coupled receptors. Chembiochem 3: 928-944.
28. Koh JY, Palmer E, Cotman CW. (1991). Activation of the metabotropic glutamate receptor attenuates N-methyl-D-aspartate neurotoxicity in cortical cultures. Proc Natl Acad Sci USA 88: 9431-9435.
29. Komarov PG, Komarova EA, Kondratov RV, Christov-Tselkov K, Coon JS, Chernov MV et al. (1999). A chemical inhibitor of p53 that protects mice from the side effects of cancer therapy. Science 285: 1733-1737.
30. Kwon YG, Min JK, Kim KM, Lee DJ, Billiar TR, Kim YM. (2001). Sphingosine 1-phosphate protects human umbilical vein endothelial cells from serum-deprived apoptosis by nitric oxide production. J Biol Chem 276: 10627-10633.
31. Lambert PF, Kashanchi F, Radonovich MF, Shiekhattar R, Brady JN. (1998). Phosphorylation of p53 serine 15 increases interaction with CBP. J Biol Chem 273: 33048-33053.
32. Li DW, Liu JP, Schmid PC, Schlosser R, Feng H, Liu WB et al. (2006). Protein serine/threonine phosphatase-1 dephosphorylates p53 at Ser-15 and Ser-37 to modulate its transcriptional and apoptotic activities. Oncogene 25: 3006-3022.
33. Marchenko ND, Zaika A, Moll UM. (2000). Death signal-induced localization of p53 protein to mitochondria. A potential role in apoptotic signaling. J Biol Chem 275: 16202-16212.
34. Marinissen MJ, Gutkind JS. (2001). G-protein-coupled receptors and signaling networks: emerging paradigms. Trends Pharmacol Sci 22: 368-376.
35. Meek DW. (1999). Mechanisms of switching on p53: a role for covalent modification? Oncogene 18: 7666-7675.
36. Miyashita T, Krajewski S, Krajewska M, Wang HG, Lin HK, Liebermann DA et al. (1994). Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene 9: 1799-1805.
37. Moll UM, Wolff S, Speidel D, Deppert W. (2005). Transcription-independent pro-apoptotic functions of p53. Curr Opin Cell Biol 17: 631-636.
38. Murga C, Laguinge L, Wetzker R, Cuadrado A, Gutkind JS. (1998). Activation of Akt/protein kinase B by G protein-coupled receptors. A role for alpha and beta gamma subunits of heterotrimeric G proteins acting through phosphatidylinositol-3-OH kinasegamma. J Biol Chem 273: 19080-19085.
39. Murph MM, Hurst-Kennedy J, Newton V, Brindley DN, Radhak-rishna H. (2007). Lysophosphatidic acid decreases the nuclear localization and cellular abundance of the p53 tumor suppressor in A549 lung carcinoma cells. Mol Cancer Res 5: 1201-1211.
40. Nakano K, Vousden KH. (2001). PUMA, a novel proapoptotic gene, is induced by p53. Mol Cell 7: 683-694.
41. Nemajerova A, Erster S, Moll UM. (2005). The post-translational phosphorylation and acetylation modification profile is not the determining factor in targeting endogenous stress-induced p53 to mitochondria. Cell Death Differ 12: 197-200.
42. Oda E, Ohki R, Murasawa H, Nemoto J, Shibue T, Yamashita T et al. (2000). Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis. Science 288: 1053-1058.
43. Park BS, Song YS, Yee SB, Lee BG, Seo SY, Park YC et al. (2005). Phospho-ser 15-p53 translocates into mitochondria and interacts with Bcl-2 and Bcl-xL in eugenol-induced apoptosis. Apoptosis 10: 193-200.
44. Paulsen MT, Starks AM, Derheimer FA, Hanasoge S, Li L, Dixon JE et al. (2006). The p53-targeting human phosphatase hCdc14A interacts with the Cdk1/cyclin B complex and is differentially expressed in human cancers. Mol Cancer 5: 25.
45. Sakaguchi K, Herrera JE, Saito S, Miki T, Bustin M, Vassilev A et al. (1998). DNA damage activates p53 through a phosphorylation-acetylation cascade. Genes Dev 12: 2831-2841.
46. Sayan BS, Sayan AE, Knight RA, Melino G, Cohen GM. (2006). p53 is cleaved by caspases generating fragments localizing to mitochondria. J Biol Chem 281: 13566-13573.
47. Shieh SY, Ikeda M, Taya Y, Prives C. (1997). DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2. Cell 91: 325-334.
48. Siliciano JD, Canman CE, Taya Y, Sakaguchi K, Appella E, Kastan MB. (1997). DNA damage induces phosphorylation of the amino terminus of p53. Genes Dev 11: 3471-3481.
49. Song P, Sekhon HS, Lu A, Arredondo J, Sauer D, Gravett C et al. (2007). M3 muscarinic receptor antagonists inhibit small cell lung carcinoma growth and mitogen-activated protein kinase phosphorylation induced by acetylcholine secretion. Cancer Res 67: 3936-3944.
50. Strom E, Sathe S, Komarov PG, Chernova OB, Pavlovska I, Shyshynova I et al. (2006). Small-molecule inhibitor of p53 binding to mitochondria protects mice from gamma radiation. Nat Chem Biol 2: 474-479.
51. Tibbetts RS, Brumbaugh KM, Williams JM, Sarkaria JN, Cliby WA, Shieh SY et al. (1999). A role for ATR in the DNA damage-induced phosphorylation of p53. Genes Dev 13: 152-157.
52. Tobin AB, Budd DC. (2003). The anti-apoptotic response of the Gq/ 11-coupled muscarinic receptor family. Biochem Soc Trans 31: 1182-1185.
53. Ullrich SJ, Mercer WE, Appella E. (1992). Human wild-type p53 adopts a unique conformational and phosphorylation state in vivo during growth arrest of glioblastoma cells. Oncogene 7: 1635-1643.
54. Unger T, Juven-Gershon T, Moallem E, Berger M, Vogt Sionov R, Lozano G et al. (1999). Critical role for Ser20 of human p53 in the negative regulation of p53 by Mdm2. EMBO J 18: 1805-1814.
55. van Koppen CJ, Kaiser B. (2003). Regulation of muscarinic acetylcho-line receptor signaling. Pharmacol Ther 98: 197-220.
56. Vichalkovski A, Baltensperger K, Thomann D, Porzig H. (2005). Two different pathways link G-protein-coupled receptors with tyrosine kinases for the modulation of growth and survival in human hematopoietic progenitor cells. Cell Signal 17: 447-459.
57. Vogelstein B, Lane D, Levine AJ. (2000). Surfing the p53 network. Nature 408: 307-310.
58. Vousden KH, Lu X. (2002). Live or let die: the cell's response to p53. Nat Rev Cancer 2: 594-604.
59. Yan GM, Lin SZ, Irwin RP, Paul SM. (1995). Activation of muscarinic cholinergic receptors blocks apoptosis of cultured cerebellar granule neurons. Mol Pharmacol 47: 248-257.
60. Yu J, Zhang L, Hwang PM, Rago C, Kinzler KW, Vogelstein B. (1999). Identification and classification of p53-regulated genes. Proc Natl Acad Sci USA 96: 14517-14522.
61. Zhou Y, Larsen PH, Hao C, Yong VW. (2002). CXCR4 is a major chemokine receptor on glioma cells and mediates their survival. J Biol Chem 277: 49481-49487.
62. Zhu WZ, Zheng M, Koch WJ, Lefkowitz RJ, Kobilka BK, Xiao RP. (2001). Dual modulation of cell survival and cell death by beta(2)-adrenergic signaling in adult mouse cardiac myocytes. Proc Natl Acad Sci USA 98: 1607-1612.